The sold production of vaccines for veterinary medicine in Spain has shown a fluctuating yet overall positive trend over the past decade. Between 2013 and 2023, the production value grew from €271.22 million to €461.87 million, achieving a year-on-year increase of 7.51% in 2023 and a CAGR of 8.76% over the last five years. Significant growth occurred from 2019 onwards, with remarkable annual growth rates reaching up to 13.35% in 2020.
Future trends point towards continued growth, with forecasts suggesting that by 2028 the production value will reach €618.32 million, driven by a five-year CAGR of 4.6%. This forecasted performance indicates a sustained demand increase for veterinary vaccines in Spain.
Key areas to watch include advancements in biotechnology, regulatory changes, and shifts in the livestock industry, which could impact production dynamics. Enhanced disease awareness and preventive measures within veterinary practices are also expected to influence future market expansions.
